Hospitalisations Due to Dental Infection: A Retrospective Clinical Audit from an Australian Public Hospital
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethical Application
2.2. Patient Selection
2.3. Date Collection
2.4. Data Analysis
3. Results
3.1. Clinical Features
3.2. Vital Signs
3.3. Time of Presentation
3.4. Previous Treatment
3.5. Demographics
3.6. Comorbidities
3.7. Teeth and Facial Space Involvement
3.8. White Blood Cell Counts and C-Reactive Protein
3.9. Imaging Modality
3.10. Management
3.11. Hospitalisations
3.12. Microbiology
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ogle, O.E.; Halpern, L.R. Odontogenic Infections: Anatomy, Etiology, and Treatment. In Oral and Maxillofacial Surgery, Medicine, and Pathology for the Clinician; Wiley: Hoboken, NJ, USA, 2023; pp. 227–241. [Google Scholar]
- Ogle, O.E. Odontogenic infections. Dent. Clin. 2017, 61, 235–252. [Google Scholar] [CrossRef] [PubMed]
- Islam, B.; Khan, S.N.; Khan, A.U. Dental caries: From infection to prevention. Med. Sci. Monit. 2007, 13, RA196–RA203. [Google Scholar] [PubMed]
- Prakash, S.K. Dental abscess: A microbiological review. Dent. Res. J. 2013, 10, 585. [Google Scholar]
- López-Píriz, R.; Aguilar, L.; Giménez, M.J. Management of odontogenic infection of pulpal and periodontal origin. Med. Oral Patol. Oral Y Cirugía Bucal 2007, 12, 154–159. [Google Scholar]
- Rastenienė, R.; Pūrienė, A.; Aleksejūnienė, J.; Pečiulienė, V.; Zaleckas, L. Odontogenic maxillofacial infections: A ten-year retrospective analysis. Surg. Infect. 2015, 16, 305–312. [Google Scholar] [CrossRef] [PubMed]
- Nadig, K.; Taylor, N. Management of odontogenic infection at a district general hospital. Br. Dent. J. 2018, 224, 962–966. [Google Scholar] [CrossRef]
- Bowe, C.M.; O’neill, M.A.; O’connell, J.E.; Kearns, G.J. The surgical management of severe dentofacial infections (DFI)—A prospective study. Ir. J. Med. Sci. 2019, 188, 327–331. [Google Scholar] [CrossRef] [PubMed]
- Allareddy, V.; Kim, M.K.; Kim, S.; Allareddy, V.; Gajendrareddy, P.; Karimbux, N.Y.; Nalliah, R.P. Hospitalizations primarily attributed to dental conditions in the United States in 2008. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2012, 114, 333–337. [Google Scholar] [CrossRef] [PubMed]
- Neal, T.W.; Schlieve, T. Complications of severe odontogenic infections: A review. Biology 2022, 11, 1784. [Google Scholar] [CrossRef]
- Ullah, M.; Irshad, M.; Yaacoub, A.; Carter, E.; Thorpe, A.; Zoellner, H.; Cox, S. Dental infection requiring hospitalisation is a public health problem in Australia: A systematic review demonstrating an urgent need for published data. Dent. J. 2023, 11, 97. [Google Scholar] [CrossRef]
- Han, J.; Liau, I.; Bayetto, K.; May, B.; Goss, A.; Sambrook, P.; Cheng, A. The financial burden of acute odontogenic infections: The South Australian experience. Aust. Dent. J. 2020, 65, 39–45. [Google Scholar] [CrossRef] [PubMed]
- Neal, T.W.; Hammad, Y.; Carr, B.R.; Schlieve, T. The cost of surgically treated severe odontogenic infections: A retrospective study using severity scores. J. Oral Maxillofac. Surg. 2022, 80, 897–901. [Google Scholar] [CrossRef] [PubMed]
- Shah, A.C.; Leong, K.K.; Lee, M.K.; Allareddy, V. Outcomes of hospitalizations attributed to periapical abscess from 2000 to 2008: A longitudinal trend analysis. J. Endod. 2013, 39, 1104–1110. [Google Scholar] [CrossRef] [PubMed]
- Tan, F.Y.; Selvaraju, K.; Audimulam, H.; Yong, Z.C.; Adnan, T.H.; Balasundram, S. Length of hospital stay among oral and maxillofacial patients: A retrospective study. J. Korean Assoc. Oral Maxillofac. Surg. 2021, 47, 25. [Google Scholar] [CrossRef] [PubMed]
- Wang, P.; Huang, Y.; Long, J. A Five-Year Retrospective Study of 746 Cases with Maxillofacial Space Infection in Western China. Infect. Drug Resist. 2022, 15, 5099–5110. [Google Scholar] [CrossRef] [PubMed]
- Kityamuwesi, R.; Muwaz, L.; Kasangaki, A.; Kajumbula, H.; Rwenyonyi, C.M. Characteristics of pyogenic odontogenic infection in patients attending Mulago Hospital, Uganda: A cross-sectional study. BMC Microbiol. 2015, 15, 46. [Google Scholar] [CrossRef] [PubMed]
- Ozdemir, D. Dental caries: The most common disease worldwide and preventive strategies. Int. J. Biol. 2013, 5, 55. [Google Scholar] [CrossRef]
- Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 2005, 43, 5721–5732. [Google Scholar] [CrossRef] [PubMed]
- Verma, S.; Chambers, I. Dental emergencies presenting to a general hospital emergency department in Hobart, Australia. Aust. Dent. J. 2014, 59, 329–333. [Google Scholar] [CrossRef]
- Biggs, A. Overview of Commonwealth Involvement in Funding Dental Care; Parliamentary Library: Hill, Australia, 2008. [Google Scholar]
- Fu, B.; McGowan, K.; Sun, H.; Batstone, M. Increasing use of intensive care unit for odontogenic infection over one decade: Incidence and predictors. J. Oral Maxillofac. Surg. 2018, 76, 2340–2347. [Google Scholar] [CrossRef]
- Michael, J.; Hibbert, S. Presentation and management of facial swellings of odontogenic origin in children. Eur. Arch. Paediatr. Dent. 2014, 15, 259–268. [Google Scholar] [CrossRef] [PubMed]
- Cope, A.L.; Chestnutt, I.G.; Wood, F.; Francis, N.A. Dental consultations in UK general practice and antibiotic prescribing rates: A retrospective cohort study. Br. J. Gen. Pract. 2016, 66, e329–e336. [Google Scholar] [CrossRef] [PubMed]
- Liau, I.; Han, J.; Bayetto, K.; May, B.; Goss, A.; Sambrook, P.; Cheng, A. Antibiotic resistance in severe odontogenic infections of the South Australian population: A 9-year retrospective audit. Aust. Dent. J. 2018, 63, 187–192. [Google Scholar] [CrossRef] [PubMed]
- Sundararajan, K.; Gopaldas, J.A.; Somehsa, H.; Edwards, S.; Shaw, D.; Sambrook, P. Morbidity and mortality in patients admitted with submandibular space infections to the intensive care unit. Anaesth. Intensive Care 2015, 43, 420–422. [Google Scholar] [PubMed]
- Fehrenbach, M.J.; Herring, S.W. Spread of dental infection. Pract. Hyg. 1997, 6, 13–19. [Google Scholar]
- Mathew, G.C.; Ranganathan, L.K.; Gandhi, S.; Jacob, M.E.; Singh, I.; Solanki, M.; Bither, S. Odontogenic maxillofacial space infections at a tertiary care center in North India: A five-year retrospective study. Int. J. Infect. Dis. 2012, 16, e296–e302. [Google Scholar] [CrossRef] [PubMed]
- Robertson, D.P.; Keys, W.; Rautemaa-Richardson, R.; Burns, R.; Smith, A.J. Management of severe acute dental infections. BMJ 2015, 350, h1300. [Google Scholar] [CrossRef] [PubMed]
- Bridgeman, A.; Wiesenfeld, D.; Hellyar, A.; Sheldon, W. Major maxillofacial infections. An evaluation of 107 cases. Aust. Dent. J. 1995, 40, 281–288. [Google Scholar] [CrossRef]
- Fu, B.; McGowan, K.; Sun, J.H.; Batstone, M. Increasing frequency and severity of odontogenic infection requiring hospital admission and surgical management. Br. J. Oral Maxillofac. Surg. 2020, 58, 409–415. [Google Scholar] [CrossRef]
- Uluibau, I.C.; Jaunay, T.; Goss, A.N. Severe odontogenic infections. Aust. Dent. J. 2005, 50 (Suppl. 2), S74–S81. [Google Scholar] [CrossRef]
- Kisely, S.; Baghaie, H.; Lalloo, R.; Siskind, D.; Johnson, N.W. A systematic review and meta-analysis of the association between poor oral health and severe mental illness. Psychosom. Med. 2015, 77, 83–92. [Google Scholar] [CrossRef] [PubMed]
- Kusumoto, J.; Iwata, E.; Huang, W.; Takata, N.; Tachibana, A.; Akashi, M. Hematologic and inflammatory parameters for determining severity of odontogenic infections at admission: A retrospective study. BMC Infect. Dis. 2022, 22, 931. [Google Scholar] [CrossRef] [PubMed]
- Fornari, V.; Souza, M.A.; Dallepiane, F.G.; Pasqualotti, A.; de Conto, F. Maxillofacial infections of dental origin: Risk factors for hospital admission. Braz. J. Oral Sci. 2024, 23, e243442. [Google Scholar] [CrossRef]
Pain (n = 102) | 101 (99%) | |
Facial swelling (n = 102) | 102 (100%) | |
Trismus (n = 102) | 41 (40.2%) | |
Dysphagia (n = 102) | 28 (27.4%) | |
Respiratory rate (n = 86) (number of breaths per minute) | M = 18.5, SD = 2.3, Mdn = 18, R = 14–31 | |
Breaths per minute > 20 | 8 (9.3%) | |
Oxygen saturation (%) (n = 100) | M = 97.6, SD = 1.6, Mdn = 98, R = 95–100 | |
Pulse rate (n = 101) | M = 91.2, SD = 16.4, Mdn = 89, R = 61–165 | |
Pulse rate > 100 | 25 (24.8%) | |
Systolic blood pressure (mmHg) (n = 96) | M = 132.5, SD = 17.1, Mdn = 130, R = 102–189 | |
Systolic blood pressure > 140 | 28 (29.2%) | |
Diastolic blood pressure (n = 95) (mmHg) | M = 82, SD = 10.1, Mdn = 82, R = 52–114 | |
Diastolic blood pressure >90 | 13 (13.7%) | |
Mean arterial pressure (n = 94) (mmHg) | M = 97.6, SD = 12.5, Mdn = 98, R = 39.4–125 | |
Mean arterial pressure > 100 | 39 (41.5%) | |
Temperature (°C) (n = 100) | M = 36.6, SD = 0.7, Mdn = 36.6, R = 35.5–39.2 | |
Temperature 37.1–38 | 18 (18%) | |
Temperature > 38 | 3 (3%) | |
Random blood sugar level (mmol/L) nondiabetic patients (n = 62) | M = 5.3, SD = 0.7, Mdn = 5.2, R = 3.7–7.2 | |
Random blood sugar level (mmol/L) diabetic patients (n = 4) | M = 15.7, SD = 8.7, Mdn = 17.2, R = 5–23.5 |
Previous treatment | 68 (66.7%) | |
Antibiotics * | 54 (52.9%) | |
Time of prescription (n = 51) | More than a week | 11 (21.6%) |
Less than a week | 40 (78.4%) | |
Two or more than two antibiotic prescriptions | 11 (20.4%) | |
Dental treatment | Extractions * +/− Antibiotics | 12 (17.6%) |
Pulp extirpations +/− Antibiotics | 8 (11.8%) | |
Types of antibiotics prescribed prior to presentations ** | Augmentin | 19 |
Amoxicillin | 15 | |
Amoxicillin plus Metronidazole | 5 | |
Cefalexin | 3 | |
Augmentin plus metronidazole | 1 | |
Cephalexin plus metronidazole | 1 | |
Clindamycin | 1 | |
Clindamycin plus metronidazole | 1 | |
Flucloxacillin plus metronidazole | 1 | |
metronidazole | 1 |
Gender | Male | 51 (50%) |
Female | 51 (50%) | |
Age (Years) | M = 40.1, SD = 11.5, Mdn = 37.5, R = 6–93 | |
Country of Birth | Australia | 84 (82.4%) |
Overseas | 18 (17.6%) | |
Aboriginality status | Aboriginal or Torres straits islanders | 7 (6.9%) |
Smoking status | Smokers | 53 (52%) |
Non-smokers | 49 (48%) | |
Smoking Frequency (cigarettes per day) | M = 11.6, SD = 7.1, Mdn = 10, R = 3–30 | |
Co-morbidity (n = 52) | Mental health issues | 25 (34.2%) |
Drug use | 17 (23.3%) | |
Allergy to penicillin | 10 (13.7%) | |
Diabetes mellitus | 5 (6.8%) | |
Hepatitis C | 4 (5.5%) | |
Cancer | 2 (2.7%) | |
Fatty liver | 2 (2.7%) | |
Myocardial infarction | 1 (1.7%) | |
Cardiomyopathy | 1 (1.7%) | |
COPD | 1 (1.7%) | |
Epilepsy | 1 (1.7%) | |
Osteoporosis | 1 (1.7%) | |
Crohn’s disease | 1 (1.7%) | |
Heavy alcohol | 1 (1.7%) | |
Hypothyroid | 1 (1.7%) | |
BMI (n = 89) | Mean = 29.9, SD = 9, Mdn = 29.1, R = 16.6–76 |
1 space (n = 37) (36%) | Buccal | 27 | |||
Canine | 8 | ||||
Sub-masseteric | 1 | ||||
Lower lip | 1 | ||||
2 spaces (n = 40) (39%) | Space 1 | Space 2 | |||
Buccal | Submandibular | 11 | |||
Buccal | Canine | 8 | |||
Buccal | Maxillary sinus | 7 | |||
Canine | Upper lip | 3 | |||
Canine | Orbital | 3 | |||
Buccal | Masticator | 2 | |||
Buccal | Palatal | 1 | |||
Buccal | Sublingual | 1 | |||
Buccal | sub masseteric | 1 | |||
Submandibular | Submental | 1 | |||
Submandibular | Masticator | 1 | |||
Submental | Lower lip | 1 | |||
3 spaces (n = 21) (21%) | Space 1 | Space 2 | Space 3 | ||
Canine | Buccal | Maxillary sinus | 4 | ||
Canine | Buccal | Upper lip | 4 | ||
Buccal | Submandibular | Masticator | 2 | ||
Submandibular | Masticator | Pharyngeal | 2 | ||
Buccal | Sub-masseteric | Pharyngeal | 1 | ||
Buccal | Sub-masseteric | Submandibular | 1 | ||
Buccal | Sub-masseteric | Masticator | 1 | ||
Buccal | Sub-masseteric | Maxillary sinus | 1 | ||
Buccal | Sublingual | Submandibular | 1 | ||
Buccal | Sublingual | Submental | 1 | ||
Buccal | Maxillary sinus | Orbital | 1 | ||
Buccal | Canine | Orbital | 1 | ||
Sublingual | Submandibular | Masticator | 1 | ||
≥4 spaces (n = 4) (4%) | Space 1 | Space 2 | Space 3 | Space 4 | |
Buccal | Sublingual | Submandibular | Pharyngeal | 1 | |
Sublingual * | Submandibular * | Submental | Sub-masseteric | 1 | |
Canine | Buccal space | Maxillary sinus | Orbital | 1 | |
Buccal | Submandibular | Masticator | Pharyngeal | 1 | |
Total Patients | 102 |
Aetiology (n = 102) | Dental caries (n = 64) | Un-restored caries | 46 (45.5%) |
Retained root caries | 14 (13.9%) | ||
Restored caries | 3 (3%) | ||
Periapical cyst | 1 (1%) | ||
Periodontal origin (n = 10) | Pericoronitis | 6 (5.9%) | |
Periodontal abscess | 4 (4%) | ||
Post extraction | 13 (12.9%) | ||
Post pulp extirpation | 8 (7.9%) | ||
Failed root canal treatment | 4 (4%) | ||
Occlusal wear | 2 (2.0%) | ||
Tooth fracture | 1 (1%) | ||
Jaw involvement | Upper jaw (Maxilla) | 49 (48%) | |
Lower jaw (Mandible) | 53 (52%) | ||
Jaw side involvement | Right | 50 (49%) | |
Left | 52 (51%) | ||
Teeth involvement (Some cases had multiple teeth involved) | Anterior teeth | Incisor teeth | 19 (15.6%) |
Canine teeth | 13 (10.6%) | ||
Premolar teeth | 39 (32%) | ||
1st and 2nd molar teeth | 38 (31.1%) | ||
3rd molar teeth | 12 (9.8%) | ||
Deciduous teeth | 1 (0.8%) | ||
Investigations | WBC (n = 91) (value × 109/L) | M = 11.2, SD = 3.4, Mdn = 11.2, R = 1.5–20.8 | |
WBC < 4 | 1 (1.1%) | ||
WBC 4 to 11 | 43 (47.2%) | ||
WBC > 11 | 47 (51.6%) | ||
CRP (n = 73) (mg/L) | M = 47.7, SD = 40.6, Mdn = 35, R = 3–186 | ||
CRP 3 to 10 | 16 (21.9%) | ||
CRP 10 to 100 | 49 (67.1%) | ||
CRP > 100 | 8 (10.9%) | ||
Imaging | Orthopantomogram | 91 (89.2%) | |
Contrast computed tomography | 75 (73.5%) | ||
Contrast computed tomography results (n = 75) | Inflammatory changes | 75 (100%) | |
Frank abscess collection | 19 (25.3%) |
Management | Non-surgical management (antibiotics) | 24 (23.5%) | |
Surgical management | 78 (76.5%) | ||
Anaesthesia | Local anaesthesia (Nepean Centre for Oral Health) | 44 (56.4%) | |
General anaesthesiia (Nepean hospital) | 34 (43.6%) | ||
Surgical options | Extractions | 63 (61.8%) | |
Incision and drainage (n = 38) (37.2%) | Intraoral | 33 (32.3%) | |
Extraoral | 1 (0.9%) | ||
Combined | 4 (3.9%) | ||
Pulp extirpation | 4 (3.9) | ||
Referral to dentist for extraction or pulp extirpation | 11 (10.8%) | ||
Intravenous antibiotics (n = 102) | Augmentin alone | 71 (69.6%) | |
Augmentin plus metronidazole | 15 (14.7%) | ||
Benzylpenicillin plus metronidazole | 4 (3.9%) | ||
Clindamycin plus metronidazole | 4 (3.9%) | ||
Clindamycin | 3 (2.9%) | ||
Metronidazole alone | 1 (0.9%) | ||
Ceftriaxone | 1 (0.9%) | ||
Bactrim plus metronidazole | 1 (0.9%) | ||
Cephazolin | 1 (0.9%) | ||
Cephazolin plus metronidazole | 1 (0.9%) | ||
Antibiotics on discharge (n = 97) | Augmentin | 77 (79.4%) | |
Augmentin plus metronidazole | 4 (4.1%) | ||
Clindamycin | 5 (5.1%) | ||
Clindamycin plus metronidazole | 3 (3.1%) | ||
Amoxicillin plus metronidazole | 2 (2%) | ||
Benzylpenicillin plus metronidazole | 2 (2%) | ||
Trimethoprim/sulfamethoxazole plus metronidazole | 1 (1%) | ||
Metronidazole | 1 (1%) | ||
Cephalexin | 1 (1%) | ||
Cephalexin plus metronidazole | 1 (1%) | ||
Length of hospital stay (days) | Total days | 271 | |
Ward days | 256 (94.5%) | ||
Intensive care unit days | 15 (5.9%) | ||
M = 2.7, SD = 1.6, Mdn = 2, R = 1–8 | |||
Complications | Airway-related complications | 5 (4.9%) | |
Eye-related complications (blurred vision and diplopia) | 1 (0.9%) | ||
Osteomyelitis | 1 (0.9%) | ||
Severe hypotension | 1 (0.9%) | ||
Hardware infection | 1 (0.9%) |
Microbiological Studies | Swab culture | 31 (30.4%) |
Blood culture | 1 (0.1%) | |
Polymerase chain reaction | 2 (2%) | |
Culture Growth | No Growth | 12 (38.7%) |
Growth | 19 (61.3%) | |
Microorganisms Isolated | Normal flora * | 12 |
Streptococcus Milleri group | 4 | |
Candida | 4 | |
Staphylococcus aureus | 2 | |
Staphylococcus epidermis | 1 | |
Lactobacilli | 1 | |
Streptococcus oralis | 1 | |
Viridin group of streptococci | 1 | |
Yeast cells | 1 | |
Susceptibility test (n = 3) | Staphylococcus aureus | 2 |
Strep Milleri group | 1 | |
Resistance to penicillin | 2 | |
Gram staining (n = 14) | Gram + polymorphs | 14 |
Gram + Cocci | 10 | |
Gram + Rods | 5 | |
Gram − Rods | 1 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ullah, M.; Irshad, M.; Yaacoub, A.; Carter, E.; Cox, S. Hospitalisations Due to Dental Infection: A Retrospective Clinical Audit from an Australian Public Hospital. Dent. J. 2024, 12, 173. https://doi.org/10.3390/dj12060173
Ullah M, Irshad M, Yaacoub A, Carter E, Cox S. Hospitalisations Due to Dental Infection: A Retrospective Clinical Audit from an Australian Public Hospital. Dentistry Journal. 2024; 12(6):173. https://doi.org/10.3390/dj12060173
Chicago/Turabian StyleUllah, Mafaz, Muhammad Irshad, Albert Yaacoub, Eric Carter, and Stephen Cox. 2024. "Hospitalisations Due to Dental Infection: A Retrospective Clinical Audit from an Australian Public Hospital" Dentistry Journal 12, no. 6: 173. https://doi.org/10.3390/dj12060173
APA StyleUllah, M., Irshad, M., Yaacoub, A., Carter, E., & Cox, S. (2024). Hospitalisations Due to Dental Infection: A Retrospective Clinical Audit from an Australian Public Hospital. Dentistry Journal, 12(6), 173. https://doi.org/10.3390/dj12060173